Yifan Pharmaceutical Co., Ltd. (002019.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
4098
First IPO Date
July 13, 2004
| Name | Title | Pay | Year Born |
| Feng Wang | Executive President | 0 | 1973 |
| William Tan | Director of Sales Team | 0 | N/A |
| Yuhong Geng | Deputy GM & Vice President | 0 | 1971 |
| Xing Lin | Deputy GM, Vice President & Director | 0 | 1986 |
| Xian Feng Cheng | Chairman of the Board of Directors, President & GM | 0 | 1968 |
| Kai Wang | Head of Accounting | 0 | N/A |
| Dawei Zhang | VP & CFO | 0 | 1981 |
| Ximing Li | Deputy GM & Vice President | 0 | 1961 |
| Deqi Feng | Board Secretary, Deputy GM, Vice President & Director | 0 | 1979 |
Yifan Pharmaceutical Co., Ltd. is a diverse company specializing in the global manufacturing and sale of various medicinal products. Its extensive portfolio includes pharmaceuticals for key therapeutic fields such as women's health, children's conditions, bone and joint disorders, and dermatological ailments. The company also supplies specific therapeutic infusion solutions, along with pantothenic acid and Provitamin B5 offerings. Further diversifying its product lines, Yifan provides traditional Chinese remedies, health products tailored for women, and drugs for treating blood tumors. Additionally, it operates as a producer of Active Pharmaceutical Ingredients (APIs), encompassing substances used in animal feed and health products, ingredients for skin and hair care, functional food additives, and a range of fine chemicals. Beyond pharmaceuticals, the company has industrial interests, manufacturing PBAT/PBS biodegradable resins and PVB films. The enterprise was established in 2000 and maintains its headquarters in Hangzhou, China. It previously operated under the name Yifan Xinfu Pharmaceutical Co., Ltd. before formally adopting its current designation, Yifan Pharmaceutical Co., Ltd., in October 2016.